VarmX B.V.

https://www.varmx.com

VarmX is a pharmaceutical spin-off from the Leiden University Medical Center (LUMC), founded in 2016 by professor Pieter Reitsma, a world leading expert in hemostasis and thrombosis. CEO is Paul Bilars, former managing director of one of LUMC’s divisions. In this capacity, he was also responsible for valorization of IP and strategic sourcing. Product development is based on R&D performed by one of the world’s leading groups in hemostasis and thrombosis at the Leiden University Medical Center (LUMC), led by professor Reitsma. The company’s leading product in development, PseudoXa, is a new therapeutic protein, based on the innovative research into the properties of a snake venom, to prevent or stop severe bleeding in patients taking factor Xa inhibitors, such as the commonly used apixaban. *

	Start	2017-06-27 splitoff before
	Predecessor	Leiden University Medical Center (LUMC)
	Industry	therapeutic protein
	Industry 2	PseudoXa
	Person	Öhrström, Jan (VarmX 202305 CEO formerly ProFibrix + ZymoGenetics + Novo Nordisk)
	Person 2	Reitsma, Pieter (VarmX BV 201706 CSO)

	Region	Leiden
	Country	Netherlands
	Street	38 B Middelweg
	City	2312 KJ Leiden
	Tel	+31-71-5156127
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: VarmX B.V.. (7/2/18). "Press Release: VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants". Leiden.

		Record changed: 2024-02-12

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for VarmX B.V.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)